Is the use of t-PA as compared with streptokinase cost effective?
Publication
, Journal Article
Rose, EA
Published in: N Engl J Med
October 12, 1995
Duke Scholars
Published In
N Engl J Med
DOI
ISSN
0028-4793
Publication Date
October 12, 1995
Volume
333
Issue
15
Start / End Page
1009
Location
United States
Related Subject Headings
- Tissue Plasminogen Activator
- Thrombolytic Therapy
- Streptokinase
- Myocardial Infarction
- Life Expectancy
- Humans
- General & Internal Medicine
- Cost-Benefit Analysis
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rose, E. A. (1995). Is the use of t-PA as compared with streptokinase cost effective? N Engl J Med, 333(15), 1009. https://doi.org/10.1056/NEJM199510123331515
Rose, E. A. “Is the use of t-PA as compared with streptokinase cost effective?” N Engl J Med 333, no. 15 (October 12, 1995): 1009. https://doi.org/10.1056/NEJM199510123331515.
Rose EA. Is the use of t-PA as compared with streptokinase cost effective? N Engl J Med. 1995 Oct 12;333(15):1009.
Rose, E. A. “Is the use of t-PA as compared with streptokinase cost effective?” N Engl J Med, vol. 333, no. 15, Oct. 1995, p. 1009. Pubmed, doi:10.1056/NEJM199510123331515.
Rose EA. Is the use of t-PA as compared with streptokinase cost effective? N Engl J Med. 1995 Oct 12;333(15):1009.
Published In
N Engl J Med
DOI
ISSN
0028-4793
Publication Date
October 12, 1995
Volume
333
Issue
15
Start / End Page
1009
Location
United States
Related Subject Headings
- Tissue Plasminogen Activator
- Thrombolytic Therapy
- Streptokinase
- Myocardial Infarction
- Life Expectancy
- Humans
- General & Internal Medicine
- Cost-Benefit Analysis
- 11 Medical and Health Sciences